Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
Dorota Zarębska‐Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 20

Showing 20 citing articles:

Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice
Jacquelynne Cervantes‐Torres, Carlos Cabello-Gutiérrez, Dolores-Adriana Ayón-Núñez, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 5
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose
Tessa Kühn, Claudius Speer, Christian Morath, et al.
Transplantation (2023) Vol. 107, Iss. 5, pp. 1139-1150
Open Access | Times Cited: 14
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2184-2197
Open Access | Times Cited: 13
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 349-361
Open Access | Times Cited: 4
Impact of the COVID-19 Pandemic on Attitudes toward Vaccination: Representative Study of Polish Society
Tomasz Sobierajski, Piotr Rzymski, Monika Wanke-Rytt
Vaccines (2023) Vol. 11, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 11
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
Piotr Rzymski
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 9
Two Kinds of Vaccine Hesitancy
Joshua Kelsall, Tom Sorell
Social Epistemology (2024), pp. 1-16
Open Access | Times Cited: 2
Social Support Mediates the Relationship between COVID-19-Related Burnout and Booster Vaccination Willingness among Fully Vaccinated Nurses
Petros Galanis, Aglaia Katsiroumpa, Panayota Sourtzi, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 46-46
Open Access | Times Cited: 12
Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies
Ming-Chen Yang, Chun-Chung Wang, Wei-Chien Tang, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283473-e0283473
Open Access | Times Cited: 6
Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study
Zhiwei Chen, Tianquan Huang, Taiyu He, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 4
Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022
Michael Edelstein, Karine Beiruti Wiegler, Hila Ben-Amram, et al.
International Journal of Infectious Diseases (2023) Vol. 135, pp. 57-62
Open Access | Times Cited: 4
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern.
Cong Ji, Junbin Jack Shao
Research Square (Research Square) (2024)
Open Access
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern.
Cong Ji, Junbin Jack Shao
Research Square (Research Square) (2024)
Open Access
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern
Cong Ji, Junbin Jack Shao
Heliyon (2024) Vol. 10, Iss. 17, pp. e36162-e36162
Open Access
A USER-FRIENDLY TOOL TO COMPUTE INFECTION PROBABILITY OF SARS-COV-2 INDOOR: THE USER GUIDE AND ITS APPLICATION IN MEDICAL PRACTICE
Benedetta Santoro, Francesca Larese Filon, E. Milotti
Journal of Mechanics in Medicine and Biology (2023) Vol. 23, Iss. 06
Closed Access | Times Cited: 1
Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice
Ning Luan, Han Cao, Yunfei Wang, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 1
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern.
Cong Ji, Junbin Shao
Research Square (Research Square) (2022)
Open Access
Epi-Clock: A sensitive platform to help understand pathogenic disease outbreaks and facilitate the response to future outbreaks of concern.
Cong Ji, Junbin Shao
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top